Comprehensive protocols with novel therapies, conventional therapies and alternative therapies.
China has become an increasingly important destination for patients seeking advanced medical treatment. Leading hospitals and medical centers provide access to innovative therapies, specialized expertise, and modern healthcare facilities across a wide range of medical conditions. International patients can benefit from comprehensive treatment programs, personalized care plans, and coordinated support throughout their medical journey.
A personalized immunotherapy that modifies a patient’s own T cells to recognize and attack cancer cells.
Depends on cancer type, biomarker expression, previous treatments, disease status, blood counts, organ function, and overall health.
A targeted treatment option with the potential for deep and durable responses, especially in certain blood cancers.
A next-generation immunotherapy that uses mRNA technology to train the immune system to recognize and attack cancer-specific targets.
Often depends on cancer type, tumor mutations or biomarkers, treatment history, and eligibility for clinical programs.
Designed to activate a patient’s immune system against cancer; may be used alone or combined with other therapies.
A regenerative medicine approach using induced pluripotent stem cells (iPSCs), which can be developed into specialized cells for disease treatment.
Depends on the specific disease, treatment type, clinical program, and patient health status.
Offers potential for creating replacement cells or new therapeutic approaches for currently difficult-to-treat conditions.
A cell therapy that uses tumor-infiltrating lymphocytes (immune cells found inside a tumor), which are expanded and activated in a laboratory before being returned to the patient.
Depends on cancer type, tumor accessibility, prior treatments, overall health, and ability to tolerate lymphodepleting chemotherapy.
Uses naturally tumor-targeting immune cells and has shown meaningful responses in certain solid tumors.
An immunotherapy using natural killer (NK) cells, which are immune cells capable of recognizing and attacking abnormal cells.
Depends on cancer type, disease status, biomarker profile, and treatment availability (clinical trials or approved programs).
Aims to enhance immune attack against cancer with potential advantages such as lower risk of some immune-related complications compared with some T-cell therapies.
A treatment that introduces, replaces, or modifies genetic material to correct or influence disease-related genes.
Depends on the genetic cause of disease, disease stage, organ function, and specific therapy requirements.
Can address the underlying genetic mechanism of certain diseases and may provide long-lasting effects after a single treatment.
Contact our specialists today to get more information and personalized guidance on the medical care you need. Our team is here to answer all your questions and help you understand the best treatment options for your condition. Reach out now to start your journey toward better health.